1. What Is the Affinity Resin Market?
The Affinity Resin Market encompasses chromatography resin media bearing specific biological ligands including Protein A, Protein G, Protein L, IMAC metal chelate, lectin, streptavidin, and antibody-based affinity ligands. These bind target biomolecules with high selectivity for capture and purification from complex biological matrices in biopharmaceutical manufacturing, research, and diagnostic applications. The market includes Protein A affinity resin for mAb capture as the largest segment and IMAC immobilised metal affinity chromatography Ni-NTA and Co-resin for His-tag fusion protein capture in research and biopharmaceutical development. It also includes streptavidin-agarose for biotin-labelled molecule capture in research. It also includes lectin affinity resin for glycoprotein characterisation, antibody-coupled affinity resin for antigen capture, and custom affinity resin for specific ligand-target applications in bioprocess and diagnostic development. These resins are consumed by biopharmaceutical manufacturers performing mAb and Fc-fusion protein Protein A capture at commercial GMP scale and protein expression research laboratories using IMAC Ni-NTA resin for His-tagged protein purification. They are also consumed by protein characterisation research groups using lectin and antibody affinity resin and diagnostic assay developers using streptavidin and antibody affinity resin for analyte capture in immunoassay development. Market scope covers all affinity chromatography resin media with specific biological ligands enabling selective biomolecule capture by molecular recognition. It excludes non-affinity ion exchange, SEC, and hydrophobic interaction chromatography resins, immunoaffinity detection reagents without chromatography resin form, and small molecule affinity ligands in solution without polymer resin carrier.
2. Affinity Resin Market Size & Forecast
3. Emerging Technologies
- Alkaline-stable affinity ligand development for GMP affinity resin CIP compliance is advancing protein-engineered recombinant affinity ligands providing resistance to 1_0 molar NaOH cleaning-in-place denaturation for extended resin lifetime above 100 cycles. Growing biopharmaceutical GMP affinity resin user interest in CIP-stable ligands for reduced resin replacement cost is motivating alkaline-stable engineered ligand development.
- Peptide ligand affinity resin development as Protein A cost alternative is advancing combinatorial peptide library screening identifying small peptide sequences binding mAb Fc regions at lower cost and leaching risk. Growing biopharmaceutical manufacturer interest in lower-cost peptide ligand alternatives providing Protein A equivalent capture selectivity is motivating synthetic peptide affinity ligand identification and resin development.
- Continuous affinity chromatography integration with upstream perfusion bioreactor is advancing steady-state affinity capture column operation continuously receiving perfusion culture harvest for intensified end-to-end continuous biopharmaceutical manufacturing. Growing biopharmaceutical intensification programme interest in continuous end-to-end manufacturing connecting perfusion cell culture with continuous Protein A capture is motivating integrated steady-state affinity chromatography system development.
- Mixed-mode affinity resin combining Protein A and hydrophobic interaction for single-step mAb polishing is advancing multi-ligand resin combining Protein A selective capture with hydrophobic polishing providing both mAb capture and aggregate removal. Growing biopharmaceutical process developer interest in column count reduction through combined capture and polish resin is motivating mixed-mode Protein A and HIC ligand resin development.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Protein A Chromatography Market.
4. Key Market Opportunity
One of the major opportunities in the Affinity Resin Market is the expansion of viral vector affinity resin demand as gene therapy programmes advance from early clinical to commercial manufacturing requiring scalable GMP-qualified AAV and lentiviral affinity capture resin meeting commercial. A significant proportion of approved and late-phase clinical gene therapy programmes require affinity purification steps not served by widely available commercial GMP affinity resin products, as viral vector affinity resin qualification for commercial gene therapy manufacturing remains earlier-stage than mAb Protein A. Scalable GMP viral vector affinity resin providing consistent AAV capsid-specific or lentiviral vector capture at commercial manufacturing batch scale enables gene therapy manufacturers to achieve clinical-to-commercial purification scale-up without complex filtration-based alternative polishing schemes. Affinity resin producers that develop GMP-certified viral vector affinity capture resin with validated vector-specific binding and scalable performance from development to commercial batch scale are positioned to capture growing gene therapy resin demand.
5. Top Companies in the Affinity Resin Market
The following organisations hold leading positions in the Affinity Resin Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Cytiva (Protein A/IMAC)
- Merck KGaA (Fractogel/IMAC)
- Qiagen (Ni-NTA)
- Pall Corporation (AAV resin)
- Navigo Proteins (custom)
- Thermo Fisher Scientific (IMAC)
- Bio-Rad
- Repligen
- Tosoh Bioscience
- JSR Life Sciences
6. Market Segmentation
The Affinity Resin Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Ligand Type | Protein A Protein G/L IMAC NTA Lectin Affin Streptavidin Custom Ligand |
| By Application | mAb Capture His-Tag Research Glycoprotein Biotin Capture Custom Bioprocess |
| By Scale | Research Analytical Preparative Scale Commercial Process |
| By End User | Biopharmaceutical Manufacturers Research Labs Diagnostic CDMO |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Affinity Resin Market trajectory over the forecast period:
IMAC Ni-NTA Resin Is the Standard Research Laboratory His-Tag Protein Purification Method.Academic, industrial, and government research laboratories expressing recombinant His-tagged proteins in E. coli, yeast, and mammalian cell expression systems routinely use Qiagen Ni-NTA agarose. Cytiva HisTrap HP IMAC resin for single-step His-tagged protein capture from cell lysate under native or denaturing conditions providing greater than 90 percent purity in one affinity step. This establishes iMAC Ni-NTA resin as the universal research-scale protein purification tool. Qiagen and Cytiva continued Ni-NTA agarose and HisTrap IMAC resin delivery to global research laboratory customers in 2024, with consistent demand from recombinant protein expression research across life science, structural biology, and drug discovery groups.
Custom Affinity Resin Development Is Enabling Novel Bioprocess Purification Platforms.Biopharmaceutical developers seeking purification alternatives to Protein A for non-antibody protein therapeutics, engineered antibody fragments, and nucleic acid therapeutics commission custom affinity resin development with peptide. Small molecule ligands providing target-specific capture selectivity as an alternative to Protein A where the target lacks Fc region or where Protein A ligand leaching from resin is unacceptable for product safety. Navigo Proteins, Novatech Chromatography, and custom resin developers continued customer-specific affinity ligand and resin development projects in 2024, growing biopharmaceutical pipeline diversity beyond standard mAb therapeutics motivating custom affinity resin development for novel target-specific purification.
Gene Therapy Viral Vector Affinity Purification Is Creating Growing Demand for Custom Affinity Resin.Adeno-associated virus AAV and lentiviral vector purification for gene therapy manufacturing programs require affinity capture resins bearing anti-capsid antibody. Natural receptor ligands providing viral vector-specific capture from mammalian cell culture harvest at purity levels enabling clinical and commercial gene therapy administration. This grows gene therapy pipeline advancement to commercial manufacturing creating demand for scalable viral vector affinity resin. Pall Corporation, Cytiva, and Thermo Fisher continued AAV and lentiviral vector affinity resin development and delivery to gene therapy CDMO and manufacturer customers in 2024. This grows gene therapy commercialisation generating consistent viral vector affinity resin demand.
For related market intelligence, see the Protein A Resin Market.
8. Segmental Analysis
By ligand type, Protein A affinity resins dominated the Affinity Resin Market in 2025, driven by mAb commercial manufacturing Protein A capture representing the largest single affinity resin revenue segment by a significant margin. Commercial biopharmaceutical mAb manufacturing Protein A capture resin consumption continues generating the highest affinity resin market demand as Protein A mAb capture at commercial multi-tonne annual production scale represents the majority of global affinity resin. IMAC resins are the fastest-growing ligand type, driven by growing research laboratory His-tag protein expression and growing biopharmaceutical development His-tagged protein characterisation and process development IMAC adoption. Growing global recombinant protein expression research and biopharmaceutical His-tagged protein development adoption of IMAC Ni-NTA and Co-NTA resin for single-step His-tag capture is generating IMAC resin growth above Protein A commercial manufacturing volume growth rates.
By application, mAb capture dominated the Affinity Resin Market in 2025, driven by commercial Protein A mAb capture generating the highest combined revenue of any single affinity resin application. Commercial mAb Protein A capture at biopharmaceutical manufacturing operations continues generating the highest affinity resin market demand as commercial mAb production scale creates by far the highest affinity resin procurement by revenue of any application. Gene therapy viral vector purification is the fastest-growing application, driven by growing AAV and lentiviral vector affinity resin demand from gene therapy clinical pipeline advancement to commercial manufacturing. Advancing gene therapy programmes from clinical to commercial manufacturing creating AAV capsid and lentiviral vector affinity resin procurement at commercial batch scale is generating viral vector affinity resin growth above mAb and IMAC research programme.
9. Regional Analysis
Regional demand patterns across the Affinity Resin Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Affinity Resin Market in 2025, holding 42.0% of the global market. The region's dominance reflects the largest concentration of biopharmaceutical mAb and protein therapeutic commercial manufacturing driving Protein A and affinity resin demand, the large US research laboratory IMAC Ni-NTA resin consumption base, and the headquarters of Cytiva, Thermo Fisher, and Pall Corporation as leading affinity resin producers. North American biopharmaceutical commercial mAb manufacturing Protein A resin demand and large US research laboratory IMAC consumption create the highest North American affinity resin market revenue as the dominant biopharmaceutical and research affinity resin geography. Growing North American gene therapy manufacturing viral vector affinity resin demand and US research laboratory IMAC expansion create consistent North American sector leadership.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 11.50% during the forecast period. Growing South Korean and Chinese biosimilar mAb manufacturing affinity resin demand, growing Asian CDMO biopharmaceutical services affinity resin consumption, and growing Asian academic and research laboratory IMAC resin adoption are driving above-average growth. South Korean and Chinese biosimilar mAb manufacturing Protein A affinity resin demand and growing Asian CDMO research and GMP manufacturing affinity resin create consistent Asia Pacific market demand growth. Growing Indian and Chinese research laboratory IMAC resin adoption and growing Asian gene therapy CDMO affinity viral vector resin demand create consistent Asia Pacific affinity resin market demand growth above European rates.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Affinity Resin Market was valued at USD 1.81 Bn in 2025 and is projected to reach USD 3.94 Bn by 2034, growing at a CAGR of 9.00% over the 2026–2034 forecast period.
The Affinity Resin Market is projected to grow at a CAGR of 9.00% from 2026 to 2034.
North America accounted for the largest share of the Affinity Resin Market in 2025, holding 42.0% of the global market.
The leading companies in the Affinity Resin Market include Cytiva (Protein A/IMAC), Merck KGaA (Fractogel/IMAC), Qiagen (Ni-NTA), Pall Corporation (AAV resin), Navigo Proteins (custom), Thermo Fisher Scientific (IMAC), Bio-Rad, Repligen, Tosoh Bioscience, JSR Life Sciences.
Imac ni-nta resin is the standard research laboratory his-tag protein purification method.
By ligand type, Protein A affinity resins dominated the Affinity Resin Market in 2025, driven by mAb commercial manufacturing Protein A capture representing the largest single affinity resin revenue segment by a significant margin.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.